109 related articles for article (PubMed ID: 17076629)
1. Pharmacokinetic analysis of platelet-activating factor in the tears of guinea pigs with allergic conjunctivitis.
Okumura N; Fukushima A; Igarashi A; Sumi T; Yamagishi T; Ueno H
J Ocul Pharmacol Ther; 2006 Oct; 22(5):347-52. PubMed ID: 17076629
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor in human normal tears.
Okumura N; Kojima K; Hashida M; Koura Y; Fukushima A; Ueno H
Curr Eye Res; 2005 Oct; 30(10):891-6. PubMed ID: 16251126
[TBL] [Abstract][Full Text] [Related]
3. Platelet activating factor degradation in tear fluid from guinea pigs with allergic conjunctivitis.
Kato M; Mano H; Ota A; Konomi K; Nakata K
J Ocul Pharmacol Ther; 2001 Feb; 17(1):83-91. PubMed ID: 11327052
[TBL] [Abstract][Full Text] [Related]
4. Characterization of receptors for platelet-activating factor in guinea pig lung membranes.
Gomez J; Bloom JW; Yamamura HI; Halonen M
Am J Respir Cell Mol Biol; 1990 Sep; 3(3):259-64. PubMed ID: 2167700
[TBL] [Abstract][Full Text] [Related]
5. Decrease of ciliary beat frequency by platelet activating factor: protective effect of ketotifen.
Kahhak L; Roche A; Dubray C; Arnoux C; Benveniste J
Inflamm Res; 1996 May; 45(5):234-8. PubMed ID: 8737746
[TBL] [Abstract][Full Text] [Related]
6. Apafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigs.
Kato M; Imoto K; Miyake H; Oda T; Miyaji S; Nakamura M
J Pharmacol Sci; 2004 Aug; 95(4):435-42. PubMed ID: 15286429
[TBL] [Abstract][Full Text] [Related]
7. Renal allograft platelet activating factor synthesis during acute cellular rejection.
Mangino MJ; Anderson CB; Murphy MK; Turk J
J Lipid Mediat; 1991; 4(1):69-81. PubMed ID: 1893087
[TBL] [Abstract][Full Text] [Related]
8. [Bioassay of Lyso-PAF platelet activating factor and it's role in bronchial asthma].
Fu J; Yu HP; Li PS
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(1):30-2, 63. PubMed ID: 8403058
[TBL] [Abstract][Full Text] [Related]
9. The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs.
Fitzgerald MF; Moncada S; Parente L
Br J Pharmacol; 1986 May; 88(1):149-53. PubMed ID: 3708213
[TBL] [Abstract][Full Text] [Related]
10. Quantification of distinct molecular species of platelet activating factor in ulcerative colitis.
Thyssen E; Turk J; Bohrer A; Stenson WF
Lipids; 1996 Mar; 31 Suppl():S255-9. PubMed ID: 8729129
[TBL] [Abstract][Full Text] [Related]
11. The role of platelet activating factor and the efficacy of apafant ophthalmic solution in experimental allergic conjunctivitis.
Kato M; Kurose T; Oda T; Miyaji S
J Ocul Pharmacol Ther; 2003 Aug; 19(4):315-24. PubMed ID: 12964956
[TBL] [Abstract][Full Text] [Related]
12. Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine.
Shin MH; Averill FJ; Hubbard WC; Chilton FH; Baroody FM; Liu MC; Naclerio RM
Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):660-6. PubMed ID: 8118633
[TBL] [Abstract][Full Text] [Related]
13. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain.
Tiberghien C; Laurent L; Junier MP; Dray F
J Lipid Mediat; 1991; 3(3):249-66. PubMed ID: 1773028
[TBL] [Abstract][Full Text] [Related]
14. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
[TBL] [Abstract][Full Text] [Related]
15. Species-specific variations in the molecular heterogeneity of the platelet-activating factor.
Ramesha CS; Pickett WC
J Immunol; 1987 Mar; 138(5):1559-63. PubMed ID: 3100641
[TBL] [Abstract][Full Text] [Related]
16. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes.
Tokumura A; Tsutsumi T; Yoshida J; Tsukatani H
Biochim Biophys Acta; 1990 May; 1044(1):91-100. PubMed ID: 2340312
[TBL] [Abstract][Full Text] [Related]
17. [Detection of platelet-activating factor in nasal lavage fluid from patients with pollinosis and experimental animals with nasal allergy].
Shirasaki H; Asakura K
Nihon Jibiinkoka Gakkai Kaiho; 1990 Mar; 93(3):420-7. PubMed ID: 2352050
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of platelet-activating factor in neutrophils isolated from Pichinde virus-infected guinea pigs.
Qian C; Liu CT; Peters CJ
J Leukoc Biol; 1992 Mar; 51(3):210-3. PubMed ID: 1541904
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor in the inflammatory exudate in the anaphylactic phase of allergic inflammation in rats.
Watanabe M; Ohuchi K; Sugidachi A; Hirasawa N; Hayashi Y; Tsurufuji S
Int Arch Allergy Appl Immunol; 1987; 84(4):396-403. PubMed ID: 3119503
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
Ring PC; Seldon PM; Barnes PJ; Giembycz MA
Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
